Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D02SAD
|
||||
| Former ID |
DNC007082
|
||||
| Drug Name |
3-(2-(4-methoxycinnamyl)phenyl)acrylic acid
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [528393] | ||
| Formula |
C19H18O3
|
||||
| Canonical SMILES |
COC1=CC=C(C=C1)C=CCC2=CC=CC=C2C=CC(=O)O
|
||||
| InChI |
1S/C19H18O3/c1-22-18-12-9-15(10-13-18)5-4-8-16-6-2-3-7-17(16)11-14-19(20)21/h2-7,9-14H,8H2,1H3,(H,20,21)/b5-4+,14-11+
|
||||
| InChIKey |
UIMOCAMZLBHNCQ-CTLAPNPFSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Prostaglandin E2 receptor, EP4 subtype | Target Info | Inhibitor | [528393] | |
| Prostaglandin E2receptor, EP2 subtype | Target Info | Inhibitor | [528393] | ||
| Prostaglandin E2 receptor EP3 subtype | Target Info | Inhibitor | [528393] | ||
| KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
| Inflammatory mediator regulation of TRP channels | |||||
| Renin secretion | |||||
| Pathways in cancerhsa04024:cAMP signaling pathway | |||||
| Pathways in cancerhsa04020:Calcium signaling pathway | |||||
| cAMP signaling pathway | |||||
| Regulation of lipolysis in adipocytes | |||||
| Pathways in cancer | |||||
| References | |||||